This week Alaina is joined by Dr. Natalie Gukasyan, a psychiatrist and clinical researcher at Johns Hopkins University. They discuss the common factors of psychotherapy and how they are affected in the psychedelic-assisted therapy models. From the "myth" or rationale of the treatment to the ritual of the practice, they cover all things related to the double-blind placebo-controlled clinical trial. Dr. Gukasyan also discusses the risks and benefits of psychedelic-assisted therapy and provides insight on the true placebo in these studies.

CW: suicide and self-injury at 26 minutes

All content published by YBOS is solely the opinions of the authors and does not reflect the opinions of any parties affiliated with the authors or any additional third parties.